May 11, 2022

May 10 Quick Takes: ‘molecular machines’ company MOMA lands $150M series B

Original source here.

Plus GPCR play Domain raises $42M and updates from OncoHost, Eisai, UCB, Idorsia and more

Recent news

September 13, 2024

OncoHost accepted to present poster at ESMO 2024

August 16, 2024

OncoHost announces three abstracts selected for presentation at WCLC 2024

Clinical Lung Cancer publishes study: 93% of oncologists adjust treatment recommendations with OncoHost’s PROphetNSCLC test

Ninety-three percent of oncologists adjust treatment recommendations with OncoHost’s PROphetNSCLC test

Matching Patients with Treatments: Developing Clinically Meaningful Diagnostics To Inform Cancer-Immunotherapy Selection

New Test Influences First-Line Therapy Decisions for Metastatic NSCLC Patients